KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Non-Current Deferred Tax Liability: 2010-2016

Historic Non-Current Deferred Tax Liability for Biomarin Pharmaceutical (BMRN) over the last 4 years, with Mar 2016 value amounting to $143.5 million.

  • Biomarin Pharmaceutical's Non-Current Deferred Tax Liability fell 25.71% to $143.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $143.5 million, marking a year-over-year decrease of 25.71%. This contributed to the annual value of $143.5 million for FY2015, which is N/A change from last year.
  • Biomarin Pharmaceutical's Non-Current Deferred Tax Liability amounted to $143.5 million in Q1 2016, which was down 0.00% from $143.5 million recorded in Q4 2015.
  • Biomarin Pharmaceutical's Non-Current Deferred Tax Liability's 5-year high stood at $193.2 million during Q1 2015, with a 5-year trough of $32.7 million in Q1 2012.
  • In the last 2 years, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability had a median value of $193.2 million in 2015 and averaged $173.3 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first rose by 14.75% in 2013, then fell by 25.71% in 2016.
  • Over the past 4 years, Biomarin Pharmaceutical's Non-Current Deferred Tax Liability (Quarterly) stood at $33.3 million in 2012, then increased by 13.74% to $37.2 million in 2013, then reached $143.5 million in 2015, then dropped by 25.71% to $143.5 million in 2016.
  • Its Non-Current Deferred Tax Liability was $143.5 million in Q1 2016, compared to $143.5 million in Q4 2015 and $193.2 million in Q3 2015.